Weight

Experts say any short-term financial benefit will be outweighed by long-term health costs related to obesityFaced with high demand for GLP-1 drugs, some American cities and states that previously covered the cost of the weight-loss medication for low-income residents and public employees have now started to restrict or eliminate coverage.The pullback stems from the dramatic increase in public spending on drugs such as Ozempic and Wegovy in recent years. Continue reading...

The 79th edition of the film festival will see work by Pedro Almodóvar, Hirokazu Kore-eda and László Nemes considered for the coveted Palme d’OrGillian Anderson, Rami Malek, Cara Delevingne and John Travolta are expected to walk the red carpet at Cannes this year, as the world’s most influential film festival unveiled an auteur-heavy lineup for its 79th edition.Competing for the coveted Palme d’Or will be new films by heavyweights Pedro Almodóvar, Hirokazu Kore-eda, Paweł Pawlikowski, László Nemes and Asghar Farhadi. Continue reading...

Called Foundayo, the tablet becomes the second one to receive FDA’s green light after Novo Nordisk’s WegovyThe US Food and Drug Administration (FDA) gave the green light on Wednesday to a new oral weight-loss medication developed by the Indianapolis-based pharmaceutical company Eli Lilly.Known as orforglipron or brand name Foundayo, the once-daily tablet becomes the second GLP-1 drug in pill form to hit the market in a short span of time, arriving after Novo Nordisk’s Wegovy pill received approval in December. Continue reading...